|
|
|
 |
Search published articles |
 |
|
Showing 2 results for Azoospermia
Hamid Shafi, Yousef-Reza Yousefnia Pasha, Mostafa Asgharpour,
Volume 2, Issue 2 (12-2016)
Abstract
Background: Azoospermia is the most challenging issue associated with infertility treatment. The aim of this study was to re-examine the relationship between plasma levels of follicle stimulating hormone (FSH) and luteinizing hormone (LH) with testicular pathology in azoospermic infertile men visiting the infertility clinic in north of Iran.
Methods: Fifty eligible azoospermic infertile men who had the medical indication of testicular biopsy for sperm retrieval in infertility clinic were included in the study. Plasma FSH and LH were measured by immunoassay. Then a bilateral testicular biopsy using Bouin’s solution as a fixative was performed under local anesthesia. The One-way analysis of variance was used to assess the differences between the groups.
Results: The plasma levels of FSH (p=0.0001) and LH (p=0.044) among infertile men with Sertoli-cell-only syndrome was significantly higher than those with hypospermatogenesis. Also, the plasma levels of FSH among infertile men with maturation arrest was significantly higher than those with hypospermatogenesis (p=0.003). There were no statistically significant differences in plasma LH levels between hypospermatogenesis and maturation arrest.
Conclusions: The findings of the present study indicated that the plasma levels of FSH and LH among infertile men with azoospermia testis correlated with the histopathological features. Therefore, it is necessary to emphasize the fact that azoospermic cases with highly-elevated plasma FSH and LH levels could be excluded from separate testicular biopsy as they are not suitable cases for conventional treatments.
John Jude Annan , Mike Addison, Anthony Enimil, Robert Aryee, Augustine Twumasi , Fati Ibrahim ,
Volume 9, Issue 2 (12-2023)
Abstract
Background: Male factor infertility, often characterized by deficiencies in sperm count, motility, and morphology, is a significant concern in the context of infertility. Azoospermia, the absence of spermatozoa in the ejaculate, represents a particularly challenging condition. This study aimed to investigate the prevalence of azoospermia among male partners of couples undergoing infertility treatment at a fertility center in Ghana.
Methods: A six-year retrospective descriptive investigation was conducted, focusing on male partners of couples seeking infertility treatment at the Emena Diagnostic and Fertility Centre. Semen analysis results indicative of azoospermia were systematically retrieved and analyzed. All samples were collected through masturbation and adhered to the stringent criteria outlined by the World Health Organization (WHO).
Results: Among 1,224 semen analyses conducted between 2015 and 2020, 67 cases of azoospermia were identified, accounting for approximately 5.5% of the total cases. Participants' ages ranged from 28 to 69 years, with a mean age of 41.0 (SD = 9.2) years. The majority of azoospermic individuals belonged to the 30–39 age group (44.8%), followed closely by the 40–49 age group (31.3%). Notably, 90% of the cases fell within the age range of 30–59 years. Analysis of semen characteristics revealed variations in viscosity and volume, with hypospermia most prevalent in the 40–49 age group.
Conclusion: This study provides valuable insights into the prevalence and characteristics of azoospermia among male partners seeking infertility treatment in Ghana. These findings contribute to a better understanding of male infertility and can inform strategies for its management and treatment in clinical settings.
|
|
